Skip to main content
SpringerLink
Log in

Neuropathie

Update 2012

Neuropathy

Update 2012

  • Leitthema
  • Published:
Der Diabetologe Aims and scope

Zusammenfassung

Der Übersichtsbeitrag beschreibt und kommentiert die wichtigsten Studien zu Epidemiologie, Diagnose und Therapie der diabetischen Polyneuropathie, kardiovaskulären autonomen Neuropathie, diabetischen Gastroparese und erektilen Dysfunktion, die 2011/Anfang 2012 publiziert wurden.

Abstract

This review article describes and comments the most important studies on epidemiology, diagnosis and treatment of diabetic polyneuropathy, cardiovascular autonomic neuropathy, diabetic gastroparesis, and erectile dysfunction published in the year 2011/early 2012.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1

Literatur

  1. Ylitalo KR, Sowers M, Heeringa S (2011) Peripheral vascular disease and peripheral neuropathy in individuals with cardiometabolic clustering and obesity: National Health and Nutrition Examination Survey 2001–2004. Diabetes Care 34:1642–1647

    Article  PubMed  Google Scholar 

  2. Moon JS, Clark VM, Beabout JW et al (2011) A controlled study of medial arterial calcification of legs: implications for diabetic polyneuropathy. Arch Neurol 68:1290–1294

    Article  PubMed  Google Scholar 

  3. Dyck PJ, Clark V, Overland C et al (2012) Impaired glycemia and diabetic polyneuropathy: the OC IG Survey. Diabetes Care 35:584–591

    Article  PubMed  Google Scholar 

  4. Bongaerts BWC, Rathmann W, Kowall B et al (2012) Post-challenge hyperglycemia is positively associated with diabetic polyneuropathy: the KORA F4 study. Diabetes Care (in press)

  5. Luo KR, Chao CC, Chen YT et al (2011) Quantitation of sudomotor innervation in skin biopsies of patients with diabetic neuropathy. J Neuropathol Exp Neurol 70:930–938

    Article  PubMed  Google Scholar 

  6. Ebenezer GJ, O’Donnell R, Hauer P et al (2011) Impaired neurovascular repair in subjects with diabetes following experimental intracutaneous axotomy. Brain 134:1853–1863

    Article  PubMed  Google Scholar 

  7. Garces-Sanchez M, Laughlin RS, Dyck PJ et al (2011) Painless diabetic motor neuropathy: a variant of diabetic lumbosacral radiculoplexus Neuropathy? Ann Neurol 69:1043–1054

    Article  PubMed  Google Scholar 

  8. Boussageon R, Bejan-Angoulvant T, Saadatian-Elahi M et al (2011) Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials. BMJ 343:d4169. DOI 10.1136/bmj.d4169

    Article  PubMed  Google Scholar 

  9. Buehler AM, Cavalcanti AB, Berwanger O et al (2011) Effect of tight blood glucose control versus conventional control in patients with type 2 diabetes mellitus: a systematic review with meta-analysis of randomized controlled trials. Cardiovasc Ther. DOI 10.1111/j.1755-5922.2011.00308.x

  10. Charles M, Ejskjaer N, Witte DR et al (2011) Prevalence of neuropathy and peripheral arterial disease and the impact of treatment in people with screen-detected type 2 diabetes: the ADDITION-Denmark study. Diabetes Care 34:2244–2249

    Article  PubMed  Google Scholar 

  11. Ziegler D, Low PA, Litchy WJ et al (2011) Efficacy and safety of antioxidant treatment with α-lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 trial. Diabetes Care 34:2054–2060

    Article  PubMed  CAS  Google Scholar 

  12. Ruggenenti P, Lauria G, Iliev IP et al (2011) Effects of manidipine and delapril in hypertensive patients with type 2 diabetes mellitus: the delapril and manidipine for nephroprotection in diabetes (DEMAND) randomized clinical trial. Hypertension 58:776–783

    Article  PubMed  CAS  Google Scholar 

  13. Bundesärztekammer (BÄK), Kassenärztliche Bundesvereinigung (KBV), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF) (2011) Nationale VersorgungsLeitlinie Neuropathie bei Diabetes im Erwachsenenalter – Langfassung. Version 1.1, 2011. http://www.diabetes.versorgungsleitlinien.de. Zugegriffen: 09. Januar 2012

  14. Dworkin RH, O’Connor AB, Audette J et al (2010) Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc 85(Suppl 3):3–14

    Article  Google Scholar 

  15. Attal N, Cruccu G, Baron R et al (2010) EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol 17:1113–e88

    Article  PubMed  CAS  Google Scholar 

  16. Tan T, Barry P, Reken S et al (2010) Pharmacological management of neuropathic pain in non-specialist settings: summary of NICE guidance. BMJ 340:c1079. DOI 10.1136/bmj.c1079

    Article  PubMed  Google Scholar 

  17. Bril V, England J, Franklin GM et al (2011) Evidence-based guideline: treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology 76:1758–1765

    Article  PubMed  CAS  Google Scholar 

  18. Moore RA, Wiffen PJ, Derry S, McQuay HJ (2011) Gabapentin for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev 16:CD007938

    Google Scholar 

  19. Kaur H, Hota D, Bhansali A et al (2011) A comparative evaluation of amitriptyline and duloxetine in painful diabetic neuropathy: a randomized, double-blind, cross-over clinical trial. Diabetes Care 34:818–822

    Article  PubMed  CAS  Google Scholar 

  20. Schwartz S, Etropolski M, Shapiro DY et al (2011) Safety and efficacy of tapentadol ER in patients with painful diabetic peripheral neuropathy: results of a randomized-withdrawal, placebo-controlled trial. Curr Med Res Opin 27:151–162

    Article  PubMed  CAS  Google Scholar 

  21. Laitinen T, Lindström J, Eriksson J et al (2011) Cardiovascular autonomic dysfunction is associated with central obesity in persons with impaired glucose tolerance. Diabet Med 28:699–704

    Article  PubMed  CAS  Google Scholar 

  22. Zilliox L, Peltier AC, Wren PA et al (2011) Assessing autonomic dysfunction in early diabetic neuropathy: the Survey of Autonomic Symptoms. Neurology 76:1099–1105

    Article  PubMed  CAS  Google Scholar 

  23. Jost WH, Papanas N, Rizos A et al (2012) Interkulturelle Adaptation des Survey of Autonomic Symptoms (SAS). Diabetologie 7:30–32

    Article  Google Scholar 

  24. Choung RS, Locke GR III, Schleck CD et al (2011) Risk of gastroparesis in subjects with type 1 and 2 diabetes in the general population. Am J Gastroenterol. DOI 10.1038/ajg.2011.310

  25. Parkman HP, Yates KP, Hasler WL et al (2011) Dietary intake and nutritional deficiencies in patients with diabetic or idiopathic gastroparesis. Gastroenterology 141:486–498

    Article  PubMed  CAS  Google Scholar 

  26. Grover M, Farrugia G, Lurken MS et al (2011) Cellular changes in diabetic and idiopathic gastroparesis. Gastroenterology 140:1575–1585

    Article  PubMed  CAS  Google Scholar 

  27. Sharma D, Morrison G, Joseph F et al (2011) The role of continuous subcutaneous insulin infusion therapy in patients with diabetic gastroparesis. Diabetologia 54:2768–2770

    Article  PubMed  CAS  Google Scholar 

  28. Chu H, Lin Z, Zhong L et al (2011) A meta-analysis: the treatment of high-frequency gastric electrical stimulation for gastroparesis. J Gastroenterol Hepatol. DOI 10.1111/j.1440-1746.2011.06999.x

  29. Dong JY, Zhang YH, Qin LQ (2011) Erectile dysfunction and risk of cardiovascular disease: meta-analysis of prospective cohort studies. J Am Coll Cardiol 58:1378–1385

    Article  PubMed  Google Scholar 

  30. Wessells H, Penson DF, Cleary P et al (2011) Effect of intensive glycemic therapy on erectile function in men with type 1 diabetes. J Urol 185:1828–1834

    Article  PubMed  Google Scholar 

  31. Gupta BP, Murad MH, Clifton MM et al (2011) The effect of lifestyle modification and cardiovascular risk factor reduction on erectile dysfunction: a systematic review and meta-analysis. Arch Intern Med 171:1797–803

    Article  PubMed  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor weist auf folgende Beziehungen hin: Forschungsunterstützung: Abbott, Eisai, Quintiles, Ergomed, Lorenz Biotech. Vortragstätigkeit: Lilly, Pfizer, Meda, Nycomed, Takeda, Eisai, Berlin-Chemie, Novo Nordisk, Med Update. Beratertätigkeit: Lilly, Pfizer, Meda, Nycomed, Wörwag, Daiichi-Sankyo, BMS, Grünenthal, Sanofi-Aventis

Author information

Authors and Affiliations

  1. Institut für Klinische Diabetologie, Deutsches Diabetes-Zentrum an der Heinrich-Heine-Universität, Leibniz-Zentrum für Diabetesforschung, Auf’m Hennekamp 65, 40225, Düsseldorf, Deutschland

    D. Ziegler FRCPE

  2. Klinik für Stoffwechselkrankheiten, Universitätsklinikum Düsseldorf, Düsseldorf, Deutschland

    D. Ziegler FRCPE

Authors
  1. D. Ziegler FRCPE
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to D. Ziegler FRCPE.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ziegler, D. Neuropathie. Diabetologe 8, 397–406 (2012). https://doi.org/10.1007/s11428-011-0856-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11428-011-0856-z

Schlüsselwörter

Keywords

Search

Navigation